Physician profile
Karina Gritsenko
NPI 1982842787
$664,684.40
in general payments reported to CMS, 2019-2025
29 companies · $141K in 2025
The $141K reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,122 · 2020: $27K · 2021: $19K · 2022: $99K · 2023: $204K · 2024: $166K · 2025: $141K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $372K · Honoraria: $72K · Travel and Lodging: $55K · Food and Beverage: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $882.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $372,143.42 |
| Honoraria | $72,480.00 |
| Travel and Lodging | $54,696.20 |
| Food and Beverage | $10,985.29 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $882.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $582,199.83 | 2020-2025 | Iovera, Exparel, Zilretta |
| Avanos Medical | $41,761.30 | 2019-2025 | On-Q Pump and Accessories |
| Vertex Pharmaceuticals Incorporated | $11,066.05 | 2024-2025 | |
| Grt US Holding, INC. | $10,212.50 | 2022 | |
| Jazz Pharmaceuticals INC. | $5,000.00 | 2020 | |
| Averitas Pharma INC. | $2,873.88 | 2023-2025 | Qutenza |
| Boston Scientific Corporation | $1,852.31 | 2019-2025 | Wavewriter Alpha Prime 16, General - Therapies, General - Pain Management |
| Baxter Healthcare | $1,550.00 | 2020-2024 | Fluid Systems - Access Systems |
| Azurity Pharmaceuticals, INC. | $1,370.00 | 2024 | |
| Instrumentation Laboratory Company | $1,200.00 | 2024 | |
| Medtronic, INC. | $986.07 | 2021-2025 | Intellis Adaptivestim, Mazor X System, Kyphon Express II Kyphopak Tray |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $857.00 | 2023 | Relistor |
| Sentynl Therapeutics, INC. | $583.00 | 2025 | |
| Becton, Dickinson and Company | $541.67 | 2023-2024 | |
| Endo Pharmaceuticals INC. | $500.00 | 2023 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $365.52 | 2022-2023 | Zynrelef |
| Nevro Corp. | $287.11 | 2021-2023 | Senza |
| Abbvie INC. | $274.76 | 2023-2025 | |
| Endo USA, INC. | $250.00 | 2024 | |
| Stimwave Technologies Incorporated | $191.04 | 2020-2022 | |
| Abbott Laboratories | $175.72 | 2021-2024 | Eterna |
| Spr Therapeutics, INC | $149.25 | 2023-2024 | Sprint Pns System |
| Globus Medical, INC. | $116.28 | 2025 | Senza |
| Cumberland Pharmaceuticals, INC. | $102.34 | 2021-2022 | |
| Saluda Medical Americas, INC. | $89.49 | 2024-2025 | Evoke |
| Trice Medical, INC. | $70.14 | 2024 | |
| Medtronic USA, INC. | $31.29 | 2020 | |
| Bard Peripheral Vascular, INC. | $15.00 | 2020 | |
| Allergan, INC. | $12.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karina Gritsenko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.